Agile Therapeutics Inc
AGRXDelisted Jun 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001261249
Agile Therapeutics Inc was delisted on Jun 3, 2024; its insiders filed their last Form 4 on Aug 26, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $496.2K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Agile Therapeutics Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +7 vs. Q2 2022
- Shares held
- 2.32M
- +1.21M (+110.4%) vs. Q2 2022
- Total value
- $683.0K
- −$599.0K (−46.7%) vs. Q2 2022
- New holders
- 9
- 8 more added
- Sold out
- 2
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $596 |
| Q4 2023 | 21 | $496.2K |
| Q3 2023 | 17 | $355.2K |
| Q2 2023 | 16 | $425.8K |
| Q1 2023 | 23 | $337.2K |
| Q4 2022 | 27 | $371.5K |
| Q3 2022 | 28 | $683.0K |
| Q2 2022 | 21 | $1.28M |
| Q1 2022 | 39 | $4.04M |
| Q4 2021 | 47 | $18.4M |
| Q3 2021 | 54 | $30.5M |
| Q2 2021 | 71 | $45.7M |
| Q1 2021 | 78 | $79.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Agile Therapeutics Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 1,015 | $0 | 0.00% | −18−1.7% | Reduced |
| Advisor Group Holdings, Inc. | 1,147 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $0 | 0.00% | −164−98.8% | Reduced |
| Wells Fargo & Company | 259 | $0 | 0.00% | +108+71.5% | Added |
| FMR LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 9 | $0 | 0.00% | +2+28.6% | Added |
| CWM, LLC | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Fifth Lane Capital, LP | 10,000 | $0 | 0.00% | +10,000 | New |
| BNP Paribas Arbitrage, SA | 43 | $13 | 0.00% | +43 | New |
| Morgan Stanley | 4,486 | $1.00K | 0.00% | +2,472+122.7% | Added |
| Aquatic Capital Management LLC | 3,700 | $1.00K | 0.00% | +3,700 | New |
| Citigroup Inc | 9,085 | $3.00K | 0.00% | −49,487−84.5% | Reduced |
| Susquehanna Fundamental Investments, LLC | 16,291 | $5.00K | 0.00% | +16,291 | New |
| Warberg Asset Management LLC | 17,500 | $5.00K | 0.00% | +17,500 | New |
| Two Sigma Investments, LP | 27,932 | $8.00K | 0.00% | −17,489−38.5% | Reduced |
| Vanguard Group Inc | 29,419 | $9.00K | 0.00% | −694−2.3% | Reduced |
| Sabby Management, LLC | 50,000 | $15.0K | 0.03% | +50,000 | New |
| UBS Group AG | 55,155 | $16.0K | 0.00% | +29,642+116.2% | Added |
| Northern Trust Corp | 53,167 | $16.0K | 0.00% | +53,167 | New |
| Jane Street Group, LLC | 69,042 | $20.0K | 0.00% | −23,305−25.2% | Reduced |
| Advisory Services Network, LLC | 76,000 | $23.0K | 0.00% | +76,000 | New |
| Investor AB | 87,754 | $26.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 151,719 | $45.0K | 0.00% | +29,264+23.9% | Added |
| Millennium Management LLC | 186,861 | $55.0K | 0.00% | +169,914+1,002.6% | Added |
| Geode Capital Management, LLC | 216,669 | $64.0K | 0.00% | +198,668+1,103.6% | Added |
| BlackRock Inc. | 303,799 | $91.0K | 0.00% | +256,227+538.6% | Added |
| LPL Financial LLC | 411,506 | $122.0K | 0.00% | +411,506 | New |
| Perceptive Advisors LLC | 532,361 | $158.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,559−100.0% | Sold out |
| Moisand Fitzgerald Tamayo, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |